Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China · Delayed Price · Currency is CNY 4.670
-0.050 (-1.06%)
Sep 10, 2026, 1:15 PM CST
SHE:002424 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 181.21 | 354.8 | 395.63 | 417.94 | 605.02 | 465.63 |
Cash & Short-Term Investments | 181.21 | 354.8 | 395.63 | 417.94 | 605.02 | 465.63 |
Cash Growth | -63.14% | -10.32% | -5.34% | -30.92% | 29.94% | -54.84% |
Accounts Receivable | 1,316 | 1,575 | 1,954 | 2,202 | 2,207 | 1,981 |
Other Receivables | 64.83 | 58.04 | 70.57 | 159.95 | 152.98 | 196.89 |
Receivables | 1,380 | 1,633 | 2,024 | 2,362 | 2,360 | 2,178 |
Inventory | 706.29 | 665.85 | 1,111 | 1,164 | 804.83 | 825.13 |
Other Current Assets | 80.39 | 69.6 | 112.43 | 70.2 | 49.71 | 34.92 |
Total Current Assets | 2,348 | 2,724 | 3,644 | 4,014 | 3,820 | 3,503 |
Property, Plant & Equipment | 1,269 | 1,329 | 1,372 | 1,188 | 1,063 | 963.73 |
Long-Term Investments | 1,334 | 1,377 | 1,336 | 1,442 | 1,447 | 1,473 |
Goodwill | 21.38 | 21.38 | 21.38 | 21.38 | 20.58 | 20.58 |
Other Intangible Assets | 189.83 | 194.29 | 208.48 | 197.25 | 205.1 | 214.86 |
Long-Term Deferred Tax Assets | 171.64 | 184.72 | 230.76 | 235.47 | 82.67 | 66.84 |
Long-Term Deferred Charges | 249.08 | 242.68 | 214.98 | 182.04 | 147.05 | 149.18 |
Other Long-Term Assets | 124.54 | 124.99 | 107.33 | 112.16 | 108.97 | 82.17 |
Total Assets | 5,709 | 6,198 | 7,135 | 7,392 | 6,894 | 6,474 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 796.71 | 764.77 | 782.95 | 904.77 | 581.28 | 403.88 |
Accrued Expenses | 5.67 | 757.15 | 1,088 | 1,151 | 328.03 | 98.38 |
Short-Term Debt | 904.82 | 1,020 | 1,432 | 1,436 | 1,481 | 1,448 |
Current Portion of Long-Term Debt | 146.32 | 50.06 | 284.55 | 0.5 | - | 201.5 |
Current Portion of Leases | - | 7 | 8.15 | 10.57 | 12.15 | 8.35 |
Current Income Taxes Payable | 8.42 | 6.21 | 9.86 | 8.4 | 13.99 | 16.94 |
Current Unearned Revenue | 91.17 | 72.51 | 75.58 | 92.75 | 155.91 | 46.17 |
Other Current Liabilities | 458.64 | 122.07 | 118.35 | 201.19 | 196.46 | 199.32 |
Total Current Liabilities | 2,412 | 2,800 | 3,800 | 3,805 | 2,768 | 2,422 |
Long-Term Debt | - | 138.63 | 49.06 | 199.78 | - | - |
Long-Term Leases | 11.26 | 13.96 | 21.95 | 39.46 | 74.53 | 57.66 |
Long-Term Unearned Revenue | 74.74 | 67.16 | 61.29 | 34.96 | 22.38 | 23.4 |
Long-Term Deferred Tax Liabilities | 3.28 | 3.39 | 3.6 | 31.08 | 33.04 | 28.81 |
Other Long-Term Liabilities | 7.61 | - | - | - | - | 64.68 |
Total Liabilities | 2,509 | 3,023 | 3,936 | 4,110 | 2,898 | 2,597 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,398 | 1,398 | 1,398 | 1,411 | 1,411 | 1,411 |
Additional Paid-In Capital | 166.27 | 166.23 | 87.45 | 174.04 | 140.96 | 159.35 |
Retained Earnings | 1,841 | 1,811 | 1,916 | 1,882 | 2,542 | 2,404 |
Treasury Stock | -219.59 | -219.59 | -219.59 | -200.21 | -100.2 | -100.2 |
Comprehensive Income & Other | -0 | -0.04 | 0.03 | 0.07 | 0.05 | 0.08 |
Total Common Equity | 3,186 | 3,156 | 3,181 | 3,267 | 3,994 | 3,875 |
Minority Interest | 14.3 | 19.28 | 18.04 | 14.89 | 2.27 | 2.29 |
Shareholders' Equity | 3,200 | 3,175 | 3,199 | 3,282 | 3,996 | 3,877 |
Total Liabilities & Equity | 5,709 | 6,198 | 7,135 | 7,392 | 6,894 | 6,474 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,062 | 1,229 | 1,796 | 1,686 | 1,567 | 1,715 |
Net Cash (Debt) | -881.19 | -874.66 | -1,400 | -1,268 | -962.25 | -1,249 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.63 | -0.67 | -0.83 | -0.92 | -0.69 | -0.84 |
Filing Date Shares Outstanding | 1,593 | 1,365 | 1,365 | 1,386 | 1,398 | 1,398 |
Total Common Shares Outstanding | 1,593 | 1,365 | 1,365 | 1,386 | 1,398 | 1,398 |
Working Capital | -63.45 | -75.98 | -156.19 | 209.03 | 1,051 | 1,081 |
Book Value Per Share | 2.00 | 2.31 | 2.33 | 2.36 | 2.86 | 2.77 |
Tangible Book Value | 2,974 | 2,940 | 2,951 | 3,049 | 3,768 | 3,639 |
Tangible Book Value Per Share | 1.87 | 2.15 | 2.16 | 2.20 | 2.70 | 2.60 |
Buildings | - | 1,166 | 939.32 | 749.31 | 747.37 | 749.65 |
Machinery | - | 992.97 | 921.61 | 906.73 | 757.09 | 672.55 |
Construction In Progress | - | 94.46 | 343.79 | 258.07 | 182.45 | 77.92 |